TNF-α

Tumor necrosis factor alpha (TNF-α) inhibitors reduce the production or signaling of a central inflammatory cytokine. In 1975 an endotoxin-induced serum factor that causes necrosis of tumors was described and named tumor necrosis factor. Cloning of human TNF in 1984 revealed a precursor related to lymphotoxin. Through its two receptors, TNF-α activates nuclear factor kappa B (NF-κB) and cell death pathways. Etanercept is a soluble receptor fusion protein that binds the cytokine, and C 87 is a small-molecule TNF-α inhibitor. In 1991 thalidomide was shown to inhibit TNF-α production by stimulated human monocytes, and its analogs lenalidomide and pomalidomide are also listed. Pathway compounds include the NF-κB inhibitor QNZ and necrostatin-1, an inhibitor of receptor-interacting protein kinase 1 (RIPK1).

Items 76-79 of 79

  • SPD304 dihydrochloride
    Cat. No.
    A26297

    SPD304 dihydrochloride

    SPD304 dihydrochloride is a selective inhibitor of tumor necrosis factor alpha (TNF-α), functioning by promoting the dissociation of TNF trimers to obstruct the interaction between TNF and its receptor. With an IC50 of 22 μM, SPD304 effectively inhibits in vitro binding of TNF-α to TNF receptor 1 (TNFR1). This compound is primarily utilized in research applications focused on inflammatory diseases and cytokine signaling pathways.

    1 mg
    $50.00
    5 mg
    $120.00
    All 6 sizes
  • (R)-Thalidomide
    Cat. No.
    A31061

    (R)-Thalidomide

    Synonyms: (R)-(+)-Thalidomide

    (R)-Thalidomide is the R-enantiomer of Thalidomide, primarily identified for its psychomotor stabilizing properties. This enantiomer exhibits a range of biological activities, including anti-inflammatory and immunomodulatory effects. It is utilized in research applications focused on neurological and hematological disorders, providing insights into therapeutic potential and mechanisms of action.

    1 mg
    $50.00
    5 mg
    $120.00
    All 4 sizes
  • EGR-1-IN-3
    Cat. No.
    A35879

    EGR-1-IN-3

    EGR-1-IN-3 is a potent disruptor of early growth response 1 (EGR-1) DNA binding. This compound effectively inhibits TNFα-induced EGR-1 binding to DNA, leading to a reduction in the expression of pro-inflammatory genes such as TSLP, IL-31, IL-6, and CCL2. EGR-1-IN-3 is valuable for research applications focused on inflammatory diseases and mechanisms of transcriptional regulation.

    5 mg
    $155.00
    10 mg
    $250.00
    All 5 sizes
  • Necrostatin-7
    Cat. No.
    A53921

    Necrostatin-7

    Synonyms: Nec-7

    Necrostatin-7 is a potent inhibitor of necroptosis, demonstrating an EC50 of 10.6 μM. It selectively modulates necroptotic signaling pathways without inhibiting recombinant RIP1 kinase. This compound is valuable for research applications focusing on cell death mechanisms, inflammation, and neurodegenerative disorders.

    2 mg
    $25.00
    5 mg
    $40.00
    All 6 sizes

Items 76-79 of 79

Added to your cart

View Cart Checkout

    Loading...